Colon Cancer Market

Colon Cancer Market: Global Industry Analysis and Forecast 2015 - 2021

Colon Cancer Market Segmented By therapies such as surgery, chemotherapy and radiation follows surgical procedures such as colonoscopy, endoscopic mucosal resection, colectomy and laparoscopy having drugs such as bevacizumab (Avastin), cetuximab (Erbitux), panitumumab (Vectibix) and regorafenib (Stivarga)

Market Overview

Colon cancer is the cancer of large intestine which form the lower part of the digestive system. The disease usually begins with a small, benign clusters of cells known as adenomatous polyps. If left untreated, these polyps may result into colon cancer. Therefore, regular screening for polyps through colonoscopy in order to prevent it transforming to colon cancer is recommended.

Change in bowel habits or blood in stool are the major symptoms of colon cancer. Attributable epidemiological factors can be precancerous growth in the colon or genetic mutation. The American Society of Clinical Oncology (ASCO) recommends patients affected with colon cancer, for testing of genetic mutation in the KRAS gene which accounts for about 30% to 40% of colon tumors.

There are three primary recommended therapies for treating colon cancer – surgery, chemotherapy and radiation. Surgical procedures such as colonoscopy, endoscopic mucosal resection, colectomy and laparoscopy are preferred in early-stage and invasive colon cancer treatment therapy. Besides, chemotherapy involves administration of drugs that destroy cancer cells, usually recommended after the surgery to reduce the risk of recurrence.

In addition, targeted drugs such as bevacizumab (Avastin), cetuximab (Erbitux), panitumumab (Vectibix) and regorafenib (Stivarga) are administered to patients with advanced colon cancer. Radiation therapy utilizes powerful X-ray radiations to kill the cancer cells left after surgery, shrink large tumors before the surgery or relieve symptoms of colon cancer. Usually combined with chemotherapy, radiation therapy aids in reducing the risk of recurrence.

According to the Colon Cancer Alliance, colon cancer is the third most commonly diagnosed and second leading cause of cancer in the U.S. Rising incidences of colon cancer and high pricing of products have attracted pharmaceutical companies to develop and market new products.

Healthcare practitioners are now cautioned with the cost-benefit ratio of colon cancer drugs owing to large presence and high pricing of products in this market. Extensive research and development in this field is expected to provide better and more effective medications in the future.

Some of the key players contributing to this market include Bedford Laboratories, Sanofi Aventis, Bayer AG, GlaxoSmithKline plc and Teva Pharmaceutical Industries Ltd.

Find Out More about the Report Coverage

Key geographies evaluated in this report are:

  • North America
    • U.S
    • Canada
  • Europe
    • France, Germany, Italy, Spain, and the UK
    • Eastern Europe
    • CIS
  • APAC
    • China
    • India
    • Japan
    • Australia
    • Others
  • Latin America
    • Argentina
    • Brazil
    • Others

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Key features of this report

  • Drivers, restraints, and challenges shaping the Colon Cancer market dynamics
  • Latest innovations and key events in the industry
  • Analysis of business strategies of the top players
  • Colon Cancer market estimates and forecasts(2015 -2021)

Market Research Methodology - Perfected through Years of Diligence

A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

Get actionable insights on Ship Repair And Maintenance Services Market

Recommendations

Elder Care Services Market

Global elder care services market is anticipated to expand at a CAGR of 7.6% and reach US$ 2.56 Bn by 2031-end..

Disinfection Robot Market

Global disinfection robots market valued at US$ 1 Bn in 2020, and is predicted to surge at a CAGR of more than 15% during the forecast period (2021–2031)..

Sleep Service Providers Market

Sleep testing services market valuation was at approx. US$ 8 Bn in 2021. The study has projected the market to increase 2.5X by end of the decade, expanding at a robust CAGR of around 9.5%.

GMP Cell Banking Service Market

As per Persistence Market Research - PMR's report, revenues of global GMP cell banking services market is expected to grow 3.2x by 2025 end as compared to 2017.

Our Clients

Our Clients